| Drug Name |
Auranofin |
| Drug ID |
BADD_D00191 |
| Description |
Auranofin is a gold salt that is capable of eliciting pharmacologic actions that suppress inflammation and stimulate cell-mediated immunity. It has subsequently been listed by the World Health Organization as a member of the antirheumatic agent category. Auranofin appears to induce heme oxygenase 1 (HO-1) mRNA. Heme oxygenase 1 is an inducible heme-degrading enzyme with anti-inflammatory properties. |
| Indications and Usage |
Used in the treatment of active, progressive or destructive forms of inflammatory arthritis, such as adult rheumatoid arthritis. |
| Marketing Status |
Prescription |
| ATC Code |
M01CB03 |
| DrugBank ID |
DB00995
|
| KEGG ID |
D00237
|
| MeSH ID |
D001310
|
| PubChem ID |
24199313
|
| TTD Drug ID |
D0L2UN
|
| NDC Product Code |
49812-0067; 54766-093 |
| Synonyms |
Auranofin | Ridaura | SK&F D 39162 | SK&F-39162 | SK&F 39162 | SK&F39162 | Crisinor | Ridauran |
